pharmaphorum
OCTOBER 24, 2022
Companies who are thinking about seeking funding via England’s new Innovative Medicines Fund (IMF) need to think through all the commercial implications, including whether spending in the IMF counts towards rebates made against sales through the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS).
Evolve Your Success
JANUARY 2, 2024
Learn all about it from the lens of surgical tech sales with Jennifer McLaughlin. Jennifer also shares her inspiring journey in the medical sales industry, breaking down several tips on becoming an effective and relatable brand ambassador. We have another special guest and she goes by the name of Jennifer McLaughlin.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CloserIQ
OCTOBER 10, 2018
Boston is emerging as one of the hottest startup cities in the country, which is great news for sales professionals. These companies are all backed by venture capital and are currently hiring in sales roles. This is by no means an exhaustive list, but here are some great companies to consider for your next sales job. ProfitWell.
Medical Device Success
SEPTEMBER 2, 2013
If you are a medical device sales manager, are you getting the most out of your team? A Sales Plan is a good start. An end of year Sales Plan may get you that bump in sales that you need to achieve or overachieve you annual goal. Only use it if the goals the sales people offer indicate that they are hungry to achieve.
Evolve Your Success
MAY 23, 2023
Virtual reality is not just a game-changer for medical sales, but a life-changer for all of us. In this episode, Samuel Adeyinka interviews David Howe to explore the world of virtual reality training for medical device sales reps. I love talking about medical devices, software, sales and business. Samuel, I’m doing great.
Pharmaceutical Technology
OCTOBER 5, 2022
Between 2009 and 2014, the time period of Biogen’s alleged misconduct, the standard of care for MS involved the use of Biogen’s immunomodulatory drugs such as Avonex (Interferon beta-1a), Tecfidera (dimethyl fumarate), and Tysabri (natalizumab). Ferry describes a popular solution among pharmaceutical companies.
pharmaphorum
NOVEMBER 17, 2022
The 2019 VPAS , just like its predecessor that was in place from 2014, has at its heart a payback mechanism. The DHSC said that this was an exceptional change, reflecting the rapid growth in sales in 2021 driven in part by COVID-19. Initial forecast growth rate of measured sales. Actual growth rate of measured sales.
Expert insights. Personalized for you.
73 
Let's personalize your content